个体外科医生对Medicare受益人胰腺切除微创手术可能性的影响
该研究基于2013–2017年Medicare全样本数据,分析12,652例开放与2,155例微创胰腺切除,发现微创比例14.6%,不同医生间微创几率中位OR达3.27(95%CI 2.98–3.56),且低容量微创医生患者90天死亡风险更高(OR=1.33,95%CI 1.16–1.59)。
要点
- 微创胰腺切除比例在不同医生间差异超过3倍(中位OR=3.27)。
- 低容量微创胰腺外科医生患者90天死亡风险升高(OR=1.33)。
- 急诊入院患者微创几率更低(OR=0.43),2017年手术者几率更高(OR=1.51)。
核心结论
- Medicare受益人接受微创胰腺切除的可能性主要受个体治疗医生影响,而非患者或手术层面因素。
研究设计与样本
- 回顾性队列研究,基于Medicare 2013–2017年100%标准分析文件,纳入接受胰腺切除的受益人,共12,652例开放手术和2,155例微创手术。
主要发现
- 未调整的微创率从最低容量三分位组的0%到最高三分位组的35.3%。
- 急诊入院患者微创几率更低(OR=0.43,95%CI 0.32–0.58),2017年手术者微创几率更高(OR=1.51,95%CI 1.28–1.79)。
- 多变量分析显示,基于个体外科医生,微创与开放胰腺切除的几率中位OR为3.27(95%CI 2.98–3.56),变异超过3倍。
- 由低容量微创胰腺切除医生手术的患者,90天死亡几率更高(OR=1.33,95%CI 1.16–1.59),且观察/预期死亡率高于高容量医生治疗的患者。
临床怎么用
- 选择微创胰腺切除时,应关注外科医生的微创手术量和经验,而非仅依赖患者或手术因素。
- 对于急诊入院患者,需谨慎评估微创胰腺切除的可行性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of the current study was to evaluate the impact of the individual surgeon on the use of minimally invasive pancreatic resection. METHODS: The Medicare 100% Standard Analytic Files were reviewed to identify Medicare beneficiaries who underwent pancreatic resection between 2013 and 2017. The impact of patient- and procedure-related factors on the likelihood of minimally invasive pancreatic resection was investigated. RESULTS: A total of 12,652 (85.4%) patients underwent open pancreatic resection, whereas minimally invasive pancreatic resection was performed in 2,155 (14.6%) patients. Unadjusted rates of minimally invasive pancreatic resection ranged from 0% in the bottom volume tertile to 35.3% in the top tertile. Although patients with emergency admission were less likely to undergo minimally invasive pancreatic resection (odds ratio = 0.43, 95% confidence interval 0.32-0.58), patients operated on more recently had a higher chance of minimally invasive pancreatic resection (year 2017; odds ratio = 1.51, 95% confidence interval 1.28-1.79). On multivariable analysis, there was over a 3-fold variation in the odds that a patient underwent minimally invasive versus open pancreatic resection based on the individual surgeon (median odds ratio = 3.27, 95% confidence interval 2.98-3.56). Patients who underwent pancreatectomy by a low-volume, minimally invasive pancreatic resection surgeon had higher odds of 90-day mortality after surgery (odds ratio = 1.33, 95% confidence interval: 1.16-1.59), as well as higher observed/expected mortality compared with individuals treated by high-volume surgeons. CONCLUSION: The likelihood of undergoing minimally invasive pancreatic resection among Medicare beneficiaries was markedly influenced by the individual treating surgeon rather than patient- or procedure-level factors.
引用
- Tsilimigras DI, Chen Q, Hyer JM, et al. The impact of individual surgeon on the likelihood of minimal invasive surgery among Medicare beneficiaries undergoing pancreatic resection. Surgery. 2020. PMID: 32948338. doi:10.1016/j.surg.2020.07.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。